IGF2BP1 and colorectal carcinoma: The short 3’ UTR variant of IGF2BP1, which lacks microRNA binding sites and is prevalent in CRC patient samples, is associated with increased protein levels that drive proliferation and survival mechanisms vital for metastasis, particularly to the liver [63].